Melatonin for Sleep: What It Does, When It Helps & What the Evidence Actually Says

Melatonin is one of the best-known sleep supplements, but it is often described too simply. It is not a switch that forces the brain to shut down. Melatonin is a hormone involved in telling the body when biological night has arrived, which is why timing and the reason for taking it matter. For some sleep problems, that signal can be useful. For others—especially persistent insomnia driven by stress, pain, breathing problems or another underlying condition—the benefit may be limited.

Quick Answer

Melatonin can help with sleep timing and certain sleep-related problems, but it is not a universal treatment for insomnia. Health Canada’s current oral melatonin monograph supports uses including sleep aid, increased total sleep time in people with sleep restriction or altered schedules, reduced sleep-onset time in people who fall asleep slowly, circadian-rhythm resetting, and jet-lag support. Research in adults is mixed, with benefits often modest and dependent on the population, formulation, timing and outcome measured.


What Is Melatonin—and What Does It Actually Do?

Your body naturally produces melatonin in response to darkness. Its central job is circadian timing: helping coordinate the 24-hour sleep-wake cycle. Light exposure at night can suppress natural melatonin production, while darkness helps signal that nighttime is approaching. Supplemental melatonin adds an external timing signal to that system.

That distinction matters. If the main problem is a shifted body clock—jet lag, delayed sleep timing or an irregular schedule—melatonin has a mechanism that fits the problem. If the main problem is something else, taking more melatonin does not automatically solve it. This is one reason the evidence looks stronger for some sleep situations than for broad, chronic insomnia.

What Does Health Canada Support for Oral Melatonin?

Health Canada updated its oral melatonin monograph on December 19, 2025. For adults 18 years and older, the monograph permits sleep-related purposes such as:

  • use as a sleep aid to help promote sleep;

  • helping increase total sleep time in people with sleep restriction or altered sleep schedules, such as shift work or jet lag;

  • helping prevent or reduce jet-lag effects in defined travel situations;

  • helping reduce the time it takes to fall asleep in people who fall asleep slowly or have delayed sleep phase disorder; and

  • helping reset the body’s sleep-wake cycle, an aspect of circadian rhythm.

Those are ingredient-level monograph uses. They are not a licence to turn every melatonin study into a Biogénique product claim. Health Canada also states that melatonin products should not make general-health maintenance claims and frames monograph use as as-needed support for occasional sleeplessness.

Does Melatonin Work? The Research Is More Nuanced Than the Marketing

The scientific literature does not support a simple yes-or-no answer. A 2024 systematic review and dose-response meta-analysis pooled 26 double-blind randomized controlled trials with 1,689 observations. Across people with insomnia and healthy volunteers, melatonin reduced sleep-onset latency and increased total sleep time, and the authors found that timing and dose influenced the response. That supports the idea that melatonin can affect sleep—but not that everyone will experience a dramatic result.

Other reviews are less enthusiastic for chronic insomnia in adults. A 2022 systematic review of 24 randomized trials concluded that, in adults with non-comorbid chronic insomnia, melatonin did not significantly improve sleep-onset latency, total sleep time or sleep efficiency. A 2023 meta-analysis focused largely on prolonged-release melatonin found statistically significant but relatively small improvements in sleep-onset measures and sleep efficiency versus placebo.

How to read that evidence

Melatonin appears most defensible as a targeted sleep-timing tool, not as a guaranteed cure for chronic insomnia. Different studies use different populations, formulations, doses, schedules and sleep outcomes, so results should not be transferred automatically to every product or every sleeper.


Timing and Dose Matter—But “More” Is Not Automatically Better

Health Canada’s current oral monograph covers 0.1–10 mg per day for most supported uses and 0.5–10 mg per day for jet lag. It directs oral melatonin to be taken as needed, 30–60 minutes before bedtime. That regulatory range is not a personalized recommendation, and a higher dose should not be assumed to produce better sleep.

Biogénique Melatonin provides 5 mg of melatonin (N-acetyl-5-methoxytryptamine) per tablet. The current Biogénique product page lists an adult dose of one tablet once per day. People who are unsure whether 5 mg is appropriate for their situation should follow the current label and speak with a health professional rather than adjusting the dose based on internet anecdotes.

Who Should Be More Careful With Melatonin?

Health Canada’s current monograph includes several important cautions. Ask a health care professional before use if you take medications for seizures, blood pressure, immune suppression, mental-state or sedation effects, steroids or blood thinners. Professional advice is also recommended for people with cardiovascular, immune, liver or kidney disease, seizure disorder, asthma or diabetes.

When using melatonin, avoid alcohol and other products that cause drowsiness, and avoid driving or operating machinery for five hours. Do not use melatonin if pregnant or breastfeeding. Stop use if an allergy occurs or if you experience headache, confusion or nausea. If sleeplessness persists for more than four weeks, Health Canada advises consulting a health care professional.

What About Melatonin for Children or Teenagers in Canada?

This changed recently and is important. Effective June 2, 2026, melatonin sold for sleep-related use in people under 18 is prescription-only in Canada. Health Canada states that licensed natural health products containing melatonin are for adults and that there are no authorized non-prescription melatonin products for sleep-related pediatric use. Biogénique’s melatonin product should therefore be discussed as an adult product, not as an over-the-counter children’s sleep solution.

Inside Biogénique Melatonin 5 mg

Biogénique Melatonin is a 30-tablet product providing 5 mg of melatonin per tablet and carrying NPN 80063547. Biogénique’s Products & Certification page identifies it as a tablet, and the current product page lists the adult dose as one tablet once daily.

The current batch-quality record for lot PK240514 adds a separate layer of information: what was actually tested in that finished lot. The certificate of analysis lists manufacture in May 2024 and expiry in April 2027. The tested lot met its listed specifications, including tablet description and physical tests, microbiological limits and specified pathogen tests. Disintegration was reported at 2 minutes against a limit of not more than 30 minutes.

Biogénique can interpret those categories through its 3X PUR™ framework—Pureté, Qualité and Performance—but 3X PUR™ is Biogénique’s framework for explaining batch data, not a certification issued by the testing laboratory. COA results also answer a different question from clinical studies: they document batch specifications; they do not prove that a product will work for every person.

A Practical Decision Framework

Before reaching for melatonin, ask what problem you are actually trying to solve:

  • Body-clock timing problem? Jet lag, delayed sleep timing or an altered schedule is a more mechanism-aligned use case.

  • Occasional difficulty falling asleep? Melatonin may help some adults, but the average benefit in trials is not necessarily dramatic.

  • Persistent insomnia for weeks? Do not keep escalating the dose. Health Canada says to seek professional advice if sleeplessness persists beyond four weeks.

  • Taking medications or managing a chronic condition? Check the Health Canada cautions and speak with a health professional before use.

  • Shopping for a product? Look beyond the front label: verify the NPN, dose, dosage form and whether batch-level quality information is available.

Frequently Asked Questions

Does melatonin make you fall asleep instantly?

No. Melatonin is better understood as a biological-night signal than as a knockout sedative. Health Canada’s oral monograph directs it to be taken as needed 30–60 minutes before bedtime, and individual response varies.

Is 5 mg of melatonin within Health Canada’s monograph range?

Yes. Five milligrams is within the current adult monograph range for supported oral uses. That does not mean 5 mg is the ideal personal dose for everyone or that more works better.

Can I use melatonin every night?

The current oral monograph frames melatonin as as-needed support for occasional sleeplessness. If sleep difficulty persists for more than four weeks, Health Canada advises consulting a health care professional. Long-term nightly use deserves its own evidence and safety discussion rather than a blanket yes or no.

Can I take melatonin with alcohol?

Health Canada says to avoid alcohol or other products that cause drowsiness while using melatonin.

Bottom Line

Melatonin can be useful, but the strongest consumer message is not “take a sleep pill.” It is “match the tool to the sleep problem.” Health Canada recognizes specific sleep and circadian uses, and clinical research supports benefits in some settings, but results in chronic adult insomnia are mixed and often modest. For adults considering Biogénique Melatonin 5 mg, the decision should combine the current label, the reason for use, medication and health-condition cautions, and realistic expectations about what melatonin can—and cannot—do.

Related Biogénique Resources

Evidence & Compliance Note

This article separates three evidence layers. (1) Biogénique product facts: 5 mg per tablet, 30 tablets, adult dose listed as one tablet once daily, NPN 80063547, and lot PK240514 batch data. (2) Health Canada ingredient-level monograph information: permitted melatonin uses, monograph dose range, timing and risk statements. (3) External scientific research: study findings that may involve different populations, doses, formulations and schedules. External research is educational and is not presented as an authorized Biogénique product claim.

References

1. Melatonin - Oral Monograph. Health Canada, Natural and Non-prescription Health Products Directorate. Source Updated December 19, 2025.

2. Notice of amendment: pediatric melatonin. Health Canada. Source Effective June 2, 2026.

3. Melatonin: What You Need To Know. National Center for Complementary and Integrative Health (NIH). Source

4. Optimizing the Time and Dose of Melatonin as a Sleep-Promoting Drug. Systematic review and dose-response meta-analysis, Journal of Pineal Research (2024). Source 26 RCTs; 1,689 observations.

5. Efficacy of melatonin for chronic insomnia. Systematic review and meta-analysis, Sleep Medicine Reviews (2022). Source 24 randomized trials; adult chronic-insomnia findings were not significant for several core sleep outcomes.

6. Efficacy of melatonin and ramelteon for acute and long-term management of insomnia disorder in adults. Systematic review and meta-analysis (2023). Source Small-to-medium effects for several prolonged-release melatonin outcomes.

7. Melatonin 5 mg product page. Biogénique. Source

8. Products & Certification. Biogénique. Source

9. Quality Control / Certificate of Analysis lookup. Biogénique. Source Lot PK240514 verified in Biogénique Drive against the corresponding COA.

Disclaimer

This article is for general educational purposes and is not medical advice. Natural health products can interact with medications and may not be appropriate for everyone. Follow the current product label and consult a qualified health care professional when appropriate, especially for persistent sleep problems, pregnancy or breastfeeding, medication use, chronic health conditions, or sleep-related melatonin use in anyone under 18 in Canada.